Oral Drugs Exempted from Medicare Part D Discount Program
This bill aims to exempt certain orally administered drugs from the Medicare Part D manufacturer discount program. This means manufacturers of these specific drugs will not be required to offer discounts, potentially affecting their availability and prices for Medicare beneficiaries.
Key points
The bill exempts orally administered drugs approved by the FDA and granted a narrow reclassification exception under Medicaid from Medicare Part D discounts.
This change could impact the costs and accessibility of certain medications for seniors and individuals with disabilities covered by Medicare.
Introduced
Citizen Poll